Related Subjects:
| Calcium Physiology
| Hypophosphataemia
| Hyperphosphataemia
About
- Phosphorus, primarily present in the body as phosphates or esters, plays a crucial role in various biological functions.
- It is an essential component of key molecules such as DNA, RNA, and certain vitamins.
- Phosphates are integral to energy production processes like glycolysis and oxidative phosphorylation.
- The concentration of phosphate in the body is tightly regulated by:
- Calcium levels
- Parathyroid hormone (PTH)
- Vitamin D
- Renal function
- Nutritionally depleted individuals have an increased phosphate requirement and are at a higher risk of developing clinically significant hypophosphataemia.
Management of Hypophosphataemia
- When to Replace Phosphate:
- Serum phosphate < 0.32 mmol/L: Immediate replacement is required, as this level is considered severe and can lead to complications such as muscle weakness, respiratory failure, or cardiac dysfunction.
- Serum phosphate 0.32–0.8 mmol/L: Replace phosphate in symptomatic patients or those with risk factors (e.g., malnutrition, alcoholism, critical illness).
- Serum phosphate > 0.8 mmol/L: Replacement is usually not required unless the patient is symptomatic.
- Oral Replacement:
- First-line treatment in mild to moderate hypophosphataemia.
- Common preparations include:
- Phosphate supplements (e.g., sodium phosphate, potassium phosphate).
- Dosage: 30–60 mmol/day, divided into 2–3 doses.
- Encourage dietary intake of phosphate-rich foods such as dairy products, meats, nuts, and whole grains.
- Intravenous Replacement:
- Indicated for severe hypophosphataemia (<0.32 mmol/L), symptomatic patients, or those unable to tolerate oral supplementation.
- Common IV formulations include potassium phosphate or sodium phosphate.
- Typical dose: 0.08–0.16 mmol/kg over 6–12 hours, adjusted based on severity and renal function.
- Administer slowly to avoid complications such as hypocalcaemia, hyperkalaemia, or hyperphosphataemia.
Monitoring and Precautions
- Regularly monitor serum phosphate, calcium, potassium, and magnesium during replacement therapy.
- Be cautious in patients with renal impairment, as they are at higher risk for hyperphosphataemia and associated complications.
- Consider stopping phosphate replacement once serum levels normalize to prevent overcorrection.